common cold
Conditions
Interventions
Trade Name: Kan Jang, oral solution
Product Name: Kan Jang, oral solution
Pharmaceutical Form: Oral solution
Other descriptive name: Justicia Adhatoda leaf soft extract
Concentration unit: mg/ml milli
Sponsors
Swedish Herbal Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • Subjects in the age group of 18-65 years, of either sex. • Subjects predominantly suffering from two or more symptoms of common cold (cough expectoration, running nose, headache, fever, sore throat, earache, malaise /fatigue and sleep disturbance) listed in Clinical Report Form (CRF) (Appendix 5). • Subjects who have given written informed consent. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: • who were ill more than three days with a common cold • with the fever higher than 38,5 °C. • suffering from accompanying illnesses such as bronchiolitis, pneumonia, pleuritis, septic infections, special bacterial infections as pneumoconiosis, angina tonsilaris, sublingual fever higher than 40.5°C, sinusitis or any other infections. • suffering from immunologically associated diseases such as multiple sclerosis, polyarthritis or rheumatic or other autoimmune diseases, • with diabetes or with serious ailments of heart, liver, kidney or brain, • suffering from any known abuse of medication, narcotics, tobacco (> 20 cigarettes/day) or alcohol. • known allergies against cut flowers, herbal spices, or bitter seeds. • being pregnant or breast-feeding, or is she trying to get pregnant? • taking any kind of medication that can affect the course of an infection (anti-inflammatory medication, antihistamines, steroids, antibiotics). • which at the first interview are judged to be not cooperative or not to be able to finalize the study, • who were unable to give voluntary consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: The objective of this clinical study is to assess the efficacy of Kan Jang Oral solution in non complicated respiratory tract infections (common cold) when it is used in the daily dose of 60 ml (30 ml two times per day). ;Secondary Objective: ;Primary end point(s): o Duration of clinical manifestations of the acute phase of disease o Relief of clinical symptoms listed in clinical report form by a physician (Appendix 5). o Cough relief effect | — |
Countries
Finland
Outcome results
None listed